U.S. Markets closed

Hemp Legalization Reported in New Farm Bill Could Help The Industry Top 20 Billion by 2020

Denver, CO, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Ubiquitech Software Corp. (UBQU), through its operating subsidiary HempLife Today™, is bringing awareness to shareholders of the impending 2018 Farm Bill that could be signed as early as this week. The bill would legalize hemp cultivation and could be a catalyst for explosive growth in the hemp and CBD Oil industry, that some forecast could top 20 billion by 2022.

The long-awaited bill would remove industrial hemp from the federal government's list of controlled substances, making it a lawful agricultural commodity at the federal level. The hemp legislation introduced by Senate Majority Leader Mitch McConnell, R-Ky., earlier this year also allows states to become the primary regulators of hemp cultivation, enables researchers to apply for federal grants and makes the crop eligible for crop insurance.

"This opens the floodgates for this industry to grow very rapidly and scale on a national level," said Bethany Gomez, director of research for Brightfield Group, a cannabis market researcher based in Chicago. (As quoted by CNBC)

The largest amount of the current $800 million U.S. hemp market is for products that include the non-psychoactive compound CBD, cannabidiol. Like the CannazALL™ CBD products created by HempLife Today™, and the Company expects this new legislation to be a boon to the industry and its growing sales platforms.

CEO James Ballas stated, “Everything we have done with HempLife Today and its CannazALL brand of quality USA grown CBD products has been to get us to this moment, and we are looking forward to this incredibly important new chapter in our industry. With all of our sales platforms in place we are looking towards explosive growth throughout 2019 and beyond.”

The Company will update shareholders on the passing of the 2018 Farm Bill and continue to update shareholders on all Company plans for 2019.

Ubiquitech Software Corp, through its subsidiaries, is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, DirectResponse (DRTV) Television, Radio, Internet Content, and traditional marketing to drive traffic to the new and emerging multi-billion dollar industries like its subsidiaries HempLifeToday™ and CryptoBuy.com

About HempLife Today™

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life-enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers, HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; its popular CBD Tinctures, Concentrated Oils, GelCaps, Skin Salve, e-liquid, and CannazALL Pets™ CBD products all offered @ www.HempLifeToday.com

About CryptoBuy

CryptoBuy.com focuses on the burgeoning new world of Crypto Currencies and is created to be a service to persons interested in tracking and trading the many existing and future Crypto Currencies worldwide.

This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact / Investor relations